Complete Blood Count and saliva parameters as an indicator for infected patients with coronavirus covid-19
Main Article Content
Abstract
Background: Coronavirus, which causes respiratory illness, has been a public health issue in recent decades. Because the clinical symptoms of infection are not always specific, it is difficult to expose all suspects to qualitative testing in order to confirm or rule out infection as a test. Methods: According to the scientific studies and investigations, seventy-three results of scientific articles and research were obtained using PubMed, Medline, Research gate and Google Scholar. The research keywords used were COVID-19, coronavirus, blood parameters, and saliva. Results: This review provides a report on the changes in the blood and saliva tests of those who are infected with the COVID-19.COVID-19 is a systemic infection that has a substantial influence on the hematological system and hemostasis, thus deviations from normal levels of laboratory tests, including the blood and saliva test show that specific testing for detecting COVID-19 infection is required. Conclusions: The blood and saliva tests aid in the clinical monitoring of the patient's health. It has advantages such as the following: it has non-invasive properties, low cost, and good stability, addition to minimum risk of infection transport.
Downloads
Article Details
Issue
Section
This work is licensed under a Creative Commons Attribution 4.0 International License.
Licenses and Copyright
The following policy applies in The Journal of Baghdad College of Dentistry (JBCD):
# JBCD applies the Creative Commons Attribution (CC BY) license to articles and other works we publish. If you submit your paper for publication by JBCD, you agree to have the CC BY license applied to your work. Under this Open Access license, you as the author agree that anyone can reuse your article in whole or part for any purpose, for free, even for commercial purposes. Anyone may copy, distribute, or reuse the content as long as the author and original source are properly cited. This facilitates freedom in re-use and also ensures that JBCD content can be mined without barriers for the needs of research.
# If your manuscript contains content such as photos, images, figures, tables, audio files, videos, etc., that you or your co-authors do not own, we will require you to provide us with proof that the owner of that content (a) has given you written permission to use it, and (b) has approved of the CC BY license being applied to their content. We provide a form you can use to ask for and obtain permission from the owner. If you do not have owner permission, we will ask you to remove that content and/or replace it with other content that you own or have such permission to use.Don't assume that you can use any content you find on the Internet, or that the content is fair game just because it isn't clear who the owner is or what license applies.
# Many authors assume that if they previously published a paper through another publisher, they own the rights to that content and they can freely use that content in their paper, but that’s not necessarily the case, it depends on the license that covers the other paper. Some publishers allow free and unrestricted re-use of article content they own, such as under the CC BY license. Other publishers use licenses that allow re-use only if the same license is applied by the person or publisher re-using the content. If the paper was published under a CC BY license or another license that allows free and unrestricted use, you may use the content in your JBCD paper provided that you give proper attribution, as explained above.If the content was published under a more restrictive license, you must ascertain what rights you have under that license. At a minimum, review the license to make sure you can use the content. Contact that JBCD if you have any questions about the license. If the license does not permit you to use the content in a paper that will be covered by an unrestricted license, you must obtain written permission from the publisher to use the content in your JBCD paper. Please do not include any content in your JBCD paper which you do not have rights to use, and always give proper attribution.
# If any relevant accompanying data is submitted to repositories with stated licensing policies, the policies should not be more restrictive than CC BY.
# JBCD reserves the right to remove any photos, captures, images, figures, tables, illustrations, audio and video files, and the like, from any paper, whether before or after publication, if we have reason to believe that the content was included in your paper without permission from the owner of the content.
How to Cite
References
Yanxiang, Z ., Xuejie, H., Meijiao, H., et al. Hydroxychloroquine use and progression or prognosis of COVID-19: a systematic review and meta-analysis. Naunyn Schmiedebergs. Arch Pharmacol. 2021; 394: 782-774.
WHO,Coronavirus (COVID-19) Dashbord.
Jin, Y.H., Zhan, Q. Y., Peng, Z.Y., et al. Chemoprophylaxis, diagnosis, treatments, and discharge management of COVID-19: An evidence-based clinical practice guideline (updated version). Mil.Med Res. 2020; 7: 41.
Gibson, P.G., Qin, L., Puah, SH. COVID-19 acute respiratory distress syndrome (ARDS): clinical features and differences from typical pre- COVID-19 ARDS. Med J Aust. 2020; 213: 54-56.
Legrand, M., Bell, S., Forni, L., et al. Pathophysiology of COVID-19-associated acute kidney injury. Nat Rev Nephrol. 2021; 17: 751-764.
Shi, F., Wang, J., Shi, J., et al. Review of artificial intelligence techniques in imaging data acquisition, segmentation, and diagnosis for COVID-19. IEEE Rev Biomed Eng. 2021; 14:4-15.
Ai, T., Yang, Z., Hou, H., et al. Correlation of chest CT and RT-PCR testing in coronavirus disease 2019 (COVID-19) in China: A report of 1014 cases. Radiol. 2020; 296: E32-E40.
Kanne, J.P. Chest CT findings in 2019 novel coronavirus (2019-nCoV) infections from Wuhan, China: Key points for the radiologist. Radiol. 2020; 295: 16–17.
Xie, X., Zhong, Z., Zhao, W., et al. Chest CT for typical Coronavirus disease 2019(COVID-19) pneumonia: Relationship to negative RT-PCR testing. Radiol. 2020; 296: E41-E45.
Inui S, Fujikawa A, Jitsu M, et al. Chest CT findings in cases from the cruise ship diamond princess with coronavirus disease (COVID-19). Radiol Cardiothorac Imaging. 2020; 7: e204002.
Zou, l., Ruan, F., Huang, M., et al . SARS-CoV-2 Viral Load in Upper Respiratory Specimens of Infected Patients. N Engl J Med. 2020; 382: 1177-9.
Azman, M., Genden, H.S., Lum, S.G., et al. Upper respiratory tract sampling in COVID-19. Malasysian J Patho. 2020; 42: 23-35.
Lagerqvist, N., Maleki, K.T., Verner-Carlsson, J, et al. Evaluation of 11 SARS-COV-2 antibody tests by using samples from patients with defined IgG antibody titers. Sci Rep. 2021; 11: 7614.
Almeida, S.M., Spalanzani, R.N., Nogueira, M.B., et al. Rapid serological tests for SARS-COV-2: Diagnostic performance of 4 commercial assays. Med Princ Pract. 2021; 30: 385-394.
15.Kundu, D., Gautam, P., Dayanand, D., et al. The role and diagnostic accuracy of serology for COVID-19.BMC Infectious Diseases. 2022; 22: 390.
Ali, L.O. Study effect of breast cancer on some hematological and biological parameters in Babylon province, Iraq J Pharm Biolo Sci. 2014; 9: 20-24.
Frater, J., Zini, G., Onofrio, G., et al. COVID-19 and the clinical hematology laboratory. Int J Lab Hematol. 2020; 42: 11–18.
Zhu, Y., Cao, X., Xu, D. Detection of morphological changes in peripheral mononuclear cells in hepatitis B virus infection using the Beckman coulter LH 750. Lab Hematolo. 2011; 1: 22-26.
Zaghloul, H., El-Sherbiny, W. Detection of occult hepatitis C and hepatitis B virus infection from peripheral blood mononuclear cells. Immunol Invest. 2010: 284-291.
Henry, B., Cheruiyot I., Vikse J., et al. Lymphopenia and neutrophilia at admission predicts severity and mortality in patients with COVID-19: A meta-analysis. Acta Bio Med Atenei Parm. 2020; 91: e2020008.
Boes, K.M., Durham, A.C . Bone marrow, Blood cells, and the lymphatic system. Pathologic Basis Veterinary Disease. 2017 : 724–804.e2.
Al-Tawfiq, J.A., Hinedi, K., Abbasi, S., et al. Hematologic, hepatic, and renal function changes in hospitalized patients with Middle East respiratory syndrome coronavirus. Int J Lab Hematol 2017; 39: 272-278.
Yan,H., Sun, Z ., Wu, J., et al. Laboratory data analysis of novel coronavirus (COVID-19) screening in 2510 patients. Clin Chim Acta. 2020; 507: 94-97.
Liu, X., Zhang, R., He, G. Hematological findings coronavirus disease 2019: indications of progression of disease. Annals of Hematology. 2020; 99: 1421-1428.
Abdulla, A.K., Salman, OA., Mahmood, AA. Study of some hematological and biochemical parameters in patients with SARS-COV-2 in Kirkuk city/Iraq.Sys Rev Pharm. 2020; 11: 515-522.
Tavakolpour, S., Rakhshandehroo, T., Wei, X., et al. Lymphopenia during the COID-19 infection: What it shows and what can be learned. Immunol Lett. 2020; 225: 31-32.
Toori, K.U., Qureshi, M.A., Chaudhry, A . Lymphopenia: Ausefule predictor of COVID-19 disease severity and mortality. Pak J Med Sci. 2021; 37: 1984-1988.
Tan L., Wang, Q., Zhang, D., et al. Lymphopenia predicts disease severity of COVID-19: a descriptive and predictive study. Signal Transduct Target Ther. 2020; 5: 33.
Karimark, K.R., Tacke, F., Dunay, L.R. Monocytes in health and disease-minireview. Eur J Microbiol Immunol. 2012; 2: 97-102.
Espinoza, V.E., Emmady, P.D. Histology, Monocytes. Bookshelf, Ntional Center for Biotechnology of Medicin, StatPearls Publishing 2022.
Knoll, R., Schultze, JL ., Schrepping, JS. Monocytes and macrophage in COVID-19. Front immunol. 2021; 12: 720109.
32.Biamonte, F., Botta, C., Mazzitelli, M., et al. Combined lymphocyte/monocyte count, D- dimer and iron status predict COVID-19 course and outcome in a long-term care facility. J Translational Med. 2021; 19: 79.
33.Anurag, A., Jha, P.K., Kumar, A . Differential White Blood Cells count in the COVID-19: A cross-sectional study of 148 patents. Diabetes Metab Syndr. 2020; 14: 2099-2102.
Lindsly, A.W., Schwartz, J.T., Rothenberg, M.E. Eosinophill responces during COVID-19 infections and coronavirus vaccination. J Allergy Clin Immunol. 2020; 146(1): 1-7.
35.Zhang, J.J., Dong, X., Cao,Y.Y., et al. Clinical characteristics of 140 patients infected with SARS-COV-2 in Whan, China. Allergy. 2020; 75(7): 1730-1741.
Murdaca, G., Gioacchino, M., Greco, M., et al. Basophils and mast cells in COVID-19 pathogenesis. Cells. 2021; 10(10): 2754.
37.Ten-Caten, F., Gonzalez-Dias, P., Castro, I., et al. In-depth analysis of laboratory parameters reveals the interplay between sex, age, and systemic inflammation in individuals with COVID-19. Int J Infect Dis. 2021; 105: 579–587.
Kazancioglu, S., Bastug, A., Ozbay, BO., et al . The role of haematological parameters in patients withCOVID-19 and influenza virus infection. Epidemiol Infect. 2020; 148: 1–16.
39.Qin, C., Zhou, L., Hu, Z., et al. Dysregulation of Immune Response in Patients With Coronavirus 2019 (COVID-19) in Wuhan, China. Clin Infect Dis. 2020; 71: 762–768.
40.Rodriguez, L., Pekkarinen, P., Lakshmikanth, T., et al. Systems-Level Immunomonitoring from Acute to Recovery Phase of Severe COVID-19. Cell Rep Med. 2020; 1: 100078.
Mao, J., Dai, R., Du, RC., et al. Hematologic changes predict clinical outcome in recovered patients with COVID-19. Ann Hematol. 2021; 100: 675–689.
Lagunas-Rangel, FL. Neutrophil-to-lymphocyte ratio and lymphocyte-to-C-reactive protein ratio in patients with severe coronavirus disease 2019(COVID-19): A meta-analysis. J Med Virol. 2020; 92: 1733-1734.
Mahmood, Z.S., Fadhil, H.Y., Adhiah, AH . Estimation of hematological parameters of disease severity in Iraq patients with COVID-19. Iraqi J Sci. 2021; 62(10): 3487-3496.
Urbano, M., Costa, E., Geraldes, C . Hematological changes in SARS-COV-2 positive patients. Hematol Transfusion Cell Therapy. 2021; 44: 218-224
Ok, F., Erdogan, O., Durmus, E., et al. Predictive values of blood urea nitrogen/creatinine ratio and other routine blood parameters on disease severity and survival of COVID-19 Ptients. J Med Virol. 2021; 93(2): 786-793.
Lu,G., Wang, J .Dynemic chang in routine blood parameters of severe COVID-19.Clin Chim Acta. 2020,508: 98-102.
Yang, H., Xu, Y., Li, Z., et al. The clinical implication of dynamic hematological parameters in COVID-19: a restrospetive study in Chongqing, China. Int J Gener Med. 2021; 14: 4073-4080.
48.Nader, E., Nougier, C., Boisson, C., et al. Increased blood viscosity and red blood cells aggregation in patients with COVID-19. Am J Hematol. 2022; 97: 283-292.
Anani, M., Amer, S.A., Kishk, R.M., et al. Evalution of blood and biochemical parameters of COVID-19 patients in Sues canal University Hospital; A retrospective study. J Infec Develo Count. 2022; 16(4): 592-599.
Gerard, D., Brahim, S.B., Lesesve, J.F., et al. Are mushroom-shaped erythrocytes an indicator of COVID-19?. Br J Haematol. 2021; 192: 230
51.Mendonca, M., Cruz, K., Pinheiro, D., et al. Dysregulation in erythrocyte dynamic caused by SARS-CoV-2 infection: possible role in shuffling the homestatic puzzle during COVID-19. Hematol Transfusion Cell Therapy. 2022; 44: 235-245.
Mancilha, E.M., Oliveira, J.S. SARS-CoV-2 association with hemoglobin and iron metabolism. Rev Assoc Med Bras. 2021; 67: 1349–135252.
Shah, A., Frost, JN., Aaron, L., et al. Systemic hypoferremia and severity of hypoxemic respiratory failure in COVID-19. Cri Care. 2020; 24: 320
Russo, A., Tellone, E., Barreca, D., et al. Implication of COVID-19 on erythrocytes functionality: redblood cell biochemical implications and morpho-functional aspects. Int J Mol Sci. 2022; 23: 2171.
Rawi, S., Wu, G.Y. Pathological of thrombocytopenia in chronic HCV infection: A review. J.Clin. translational hepatology. 2020; 8(2): 184-191.
Lippi, G., Plebani, M., Henry, MM. Thrombocytopenia is associated with sever coronavirus disease2019(COVID-19) infections: Ameta analysis. Clin Chim Acta. 2020; 506: 145-148.
Kasinathan, G., Sathar, J. Haematological manifestations,mechanisms of thrombosis and anti-coagulation in COVID-19 disease;A review. Ann Med Surg. 2020; 56:173-177.
Singh, A., Verma, S.P., Kushwaha, R., et al. Haematological canges in the second wave of SARS-CoV-2 in north India. Cureus. 2022,; 14: e23495.
59.Valentine-Graves, M., Hall, E., Guest, J.L., et al. At-home self-collection of saliva, oropharyngeal swabs and dried blood spots for SARS-CoV-2 diagnosis and serology: post-collection acceptability of specimen collection process and patient confidence in specimens. PloS One. 2020; 15: e0236775.
To K.K., Tsang, O.T., Yip, C.C., et al. Consistent detection of 2019 novel coronavirus in saliva. Clin Infect Dis. 2020; 71: 841–843.
61.Berenger, B.M., Conly, J.M., Fonseca, K., et al. Saliva collected in universal transport media is an effective, simple and high-volume amenable method to detect SARS-CoV-2. Clin Microbiol Infect. 2020; 27: 656–657.
Matic, N., Stefanovic, A., Leung, V., et al. Practical challenges to the clinical implementation of saliva for SARS-CoV-2 detection. Eur J Clin Microbiol Infect Dis. 2020; 40: 1–4
63.Chen, L., Zhao, J., Peng, J., et al. Detection of SARS-CoV-2 in saliva and characterization of oral symptoms in COVID-19 patients. Cell Prolif. 2020; 53: e12923.
Liu, Y., Yan, L.M., Wan, L., et al. Viral dynamics in mild and severe cases of COVID-19.Lancet Infect Dis 2020; 20: 656–657.
65.Silva, J., Lucas, C., Sundaram, M., et al. Saliva viral load is a dynamic unifying correlate of COVID-19 severity and mortality. Med Rxiv, preprint 2021 doi: 10.1101/2021.01.04.21249236.
66.Huang, N., Kato, T., Mikami, Y., et al. SARS-CoV-2 infection of the oral cavity and saliva. Nat Med. 2021; 27: 892-903.
67.Drozdzik, A., Drozdzik, M. Oral pathology in COVID-19 and SARS-CoV-2 infection-molecular aspects. Int J Mol Sci. 2022; 23: 1431.
Sakaguchi, W., Kubota, N., Shimizu, T., et al. Existence of SARS-CoV-2 Entry molecules in the oral cavity. Int J Mol Sci. 2020; 21: 6000.
Sasikala, M., Sadhana, Y., Vijayasarathy, K., et al. Comparison of saliva with healthcare worker-and patient-collected swabs in the diagnosis of COVID-19 in the a large cohort. BMC Infect Dis. 2021; 21: 648
Alkhateeb, K.J., Cahill, M.N., Ross, S.A., et al. The reliability of saliva for the detection of SARS-CoV-2 in symptomatic and asymptomatic patients: Insights on the diagnostic performance and utility for COVID-19 screening. Diagn Microbiol Infect Dis. 2021; 101(3): 115450.
Goode, MR., Cheong, SY., Li, N., et al. Collection and extraction of saliva DNA for next generation sequencing. J Vis Exp. 2014; 4: 253.
Ishikawa, S., Sugimoto, M., Kitabatake, K., et al. Identification of salivary metabolomic biomarkers for oral cancer screening. Sci Rep. 2016; 6: 31520.
Erupean Center Disease Prevention and Control (ECDC),Technical report. Considration for the use of saliva as sample material for COVID-19 testing. 2021,Stockholm.